Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Boehringer Ingelheim
Dow
Harvard Business School
Merck

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: oritavancin diphosphate


Email this page to a colleague

« Back to Dashboard

oritavancin diphosphate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Melinta Therap KIMYRSA oritavancin diphosphate POWDER;INTRAVENOUS 214155 NDA Melinta Therapeutics, LLC 70842-225-01 1 VIAL in 1 CARTON (70842-225-01) > 40 mL in 1 VIAL 2021-03-23
Melinta Therap ORBACTIV oritavancin diphosphate POWDER;INTRAVENOUS 206334 NDA Melinta Therapeutics, LLC 70842-140-03 3 VIAL, GLASS in 1 CARTON (70842-140-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01) 2014-09-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Harvard Business School
Colorcon
McKinsey
Merck